The California Institute for Regenerative Medicine (CIRM) has a mission to accelerate stem cell treatments to patients with unmet medical needs. This perspective describes successful examples of work funded by CIRM's New Cell Lines and Tools and Technologies Initiatives, which were developed to address bottlenecks to stem cell research and translation. The tools developed through these programs evolved from more discovery-oriented technologies, such as disease models, differentiation processes, and assays, to more translation focused tools, including scalable good manufacturing processes, animal models, and tools for clinical cell delivery. These tools are available to the research community and many are facilitating translation of regenerative therapeutics today.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519770PMC
http://dx.doi.org/10.1002/sctm.20-0055DOI Listing

Publication Analysis

Top Keywords

stem cell
12
tools technologies
8
cell
5
tools
5
cirm tools
4
technologies breaking
4
breaking bottlenecks
4
bottlenecks development
4
development stem
4
cell therapies
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!